Clinical Study

Risk Factors for Developing Nonmelanoma Skin Cancer after Lung Transplantation

Table 4

Binary logistic regression of risk factors for NMSC or precancerous lesions after lung transplantation.

OR (95% CI)
VariableUnivariate AnalysisP valueMultivariable AnalysiP value

Male sex2.41 (0.99 – 5.88).054.01 (1.43 – 11.22).008
Higher age at first lung transplantation, y1.04 (0.99 – 1.09).061.06 (1.01 – 1.12).02
Fair ski2.27 (0.87 – 5.88).093.01 (1.02 – 8.93).0
Time of voriconazole exposure, 1.06 (0.99 – 1.14).111.11 (1.00 – 1.23).04
High UV exposure after LTx0.60 (0.30 – 1.20).150.76 (0.33 – 1.72).50
Minimal sunscreen usage before LTx1.10 (0.44 – 2.75).84NANA
High UV exposure before LTx0.86 (0.45 – 1.66).65NANA
Minimal sunscreen usage after LTX2.19 (0.61 – 7.81).23NANA
Immunosuppression without everolimu1.27 (0.43 – 3.78).66NANA

OR, odds ratio; CI, confidence interval; UV, ultra violet; NA, not applicable.
The final model exhibited an overall significance (P=.001, Nagelkerkes R2=.27).
Representing Fitzpatrick skin types I and II.
P=.047.
Calculated cumulating all periods of voriconazole intake.
Patients not continuously receiving everolimus from LTx to dermatologic examination.